134 related articles for article (PubMed ID: 13775336)
1. The hemolytic effect of primaquine. XI. Decreased catalase activity in primaquine-sensitive erythrocytes.
TARLOV AR; KELLERMEYER RW
J Lab Clin Med; 1961 Aug; 58():204-16. PubMed ID: 13775336
[No Abstract] [Full Text] [Related]
2. The hemolytic effect of primaquine. XIII. Gradient susceptibility to hemolysis of primaquine-sensitive erythrocytes.
KELLERMEYER RW; TARLOV AR; SCHRIER SL; CARSON PE; ALVING AS
J Lab Clin Med; 1961 Aug; 58():225-33. PubMed ID: 13752331
[No Abstract] [Full Text] [Related]
3. The hemolytic effect of primaquine. X. Aldolase and glyceraldehyde-3-phosphate dehydrogenase activity in primaquine-sensitive erythrocytes.
SCHRIER SL; KELLERMEYER RW; CARSON PE; ICKES CE; ALVING AS
J Lab Clin Med; 1959 Aug; 54():232-40. PubMed ID: 14443591
[No Abstract] [Full Text] [Related]
4. The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes.
BEUTLER E; DERN RJ; ALVING AS
J Lab Clin Med; 1954 Aug; 44(2):177-84. PubMed ID: 13184225
[No Abstract] [Full Text] [Related]
5. The hemolytic effect of primaquine. IX. Enzymatic abnormalities in primaquine-sensitive erythrocytes.
SCHRIER SL; KELLERMEYER RW; CARSON PE; ICKES CE; ALVING AS
J Lab Clin Med; 1958 Jul; 52(1):109-17. PubMed ID: 13549855
[No Abstract] [Full Text] [Related]
6. IN VIVO GENERATION OF H2O2 IN MOUSE ERYTHROCYTES BY HEMOLYTIC AGENTS.
COHEN G; HOCHSTEIN P
J Pharmacol Exp Ther; 1965 Jan; 147():139-43. PubMed ID: 14255158
[No Abstract] [Full Text] [Related]
7. GENERATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES BY HEMOLYTIC AGENTS.
COHEN G; HOCHSTEIN P
Biochemistry; 1964 Jul; 3():895-900. PubMed ID: 14214074
[No Abstract] [Full Text] [Related]
8. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis.
KELLERMEYER RW; TARLOV AR; BREWER GJ; CARSON PE; ALVING AS
JAMA; 1962 May; 180():388-94. PubMed ID: 14454972
[No Abstract] [Full Text] [Related]
9. The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes.
BEUTLER E; DERN RJ; FLANAGAN CL; ALVING AS
J Lab Clin Med; 1955 Feb; 45(2):286-95. PubMed ID: 13233657
[No Abstract] [Full Text] [Related]
10. The hemolytic effect of primaquine. VI. An in vitro test for sensitivity of erythrocytes to primaquine.
BEUTLER E; DERN RJ; ALVING AS
J Lab Clin Med; 1955 Jan; 45(1):40-50. PubMed ID: 13233626
[No Abstract] [Full Text] [Related]
11. Effect of intermittent administration of a combination of amodiaquin and primaquine (Camoprim) on the hematocrit of primaquine-sensitive and non-sensitive children.
HODGKINSON R; COURTNEY KO; HAGGERTY M
Am J Trop Med Hyg; 1961 Mar; 10():128-34. PubMed ID: 13714859
[No Abstract] [Full Text] [Related]
12. The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis.
BREWER GJ; TARLOV AR; ALVING AS
JAMA; 1962 May; 180():386-8. PubMed ID: 13872968
[No Abstract] [Full Text] [Related]
13. The hemolytic effect of primaquine. XV. Role of methemoglobin.
BREWER GJ; TARLOV AR; KELLERMEYER RW; ALVING AS
J Lab Clin Med; 1962 Jun; 59():905-17. PubMed ID: 13872969
[No Abstract] [Full Text] [Related]
14. The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character.
DERN RJ; BEUTLER E; ALVING AS
J Lab Clin Med; 1954 Aug; 44(2):171-6. PubMed ID: 13184224
[No Abstract] [Full Text] [Related]
15. The hemolytic effect of primaquine. XIV. Pentose metabolism in primaquine-sensitive erythrocytes.
KELLERMEYER RW; CARSON PE; SCHRIER SL; TARLOV AR; ALVING AS
J Lab Clin Med; 1961 Nov; 58():715-24. PubMed ID: 14454971
[No Abstract] [Full Text] [Related]
16. The hemolytic effect of primaquine and related compounds: a review.
BEUTLER E
Blood; 1959 Feb; 14(2):103-39. PubMed ID: 13618370
[No Abstract] [Full Text] [Related]
17. Primaquine-sensitivity of red cells in various races in Southern Africa.
CHARLTON RW; BOTHWELL TH
Br Med J; 1961 Apr; 1(5230):941-4. PubMed ID: 13692499
[No Abstract] [Full Text] [Related]
18. The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals.
DERN RJ; WEINSTEIN IM; LEROY GV; TALMAGE DW; ALVING AS
J Lab Clin Med; 1954 Feb; 43(2):303-9. PubMed ID: 13130947
[No Abstract] [Full Text] [Related]
19. [Effect of x-rays on catalase activity. II. Catalase activity of irradiated hemolysates of rabbit blood].
JONDERKO G
Arch Immunol Ther Exp (Warsz); 1960; 8():525-9. PubMed ID: 13790470
[No Abstract] [Full Text] [Related]
20. HEMOLYTIC EFFECT OF PRIMAQUINE. XVI. GLYOXALASE ACTIVITY OF PRIMAQUINE-SENSITIVE AND NORMAL ERYTHROCYTES.
BREWER GJ; POWELL RD; TARLOV AR; ALVING AS
J Lab Clin Med; 1964 Jan; 63():106-21. PubMed ID: 14102892
[No Abstract] [Full Text] [Related]
[Next] [New Search]